CA2216260A1 - Methode pour diagnostiquer la carence en hormone de croissance hypophysaire - Google Patents

Methode pour diagnostiquer la carence en hormone de croissance hypophysaire Download PDF

Info

Publication number
CA2216260A1
CA2216260A1 CA 2216260 CA2216260A CA2216260A1 CA 2216260 A1 CA2216260 A1 CA 2216260A1 CA 2216260 CA2216260 CA 2216260 CA 2216260 A CA2216260 A CA 2216260A CA 2216260 A1 CA2216260 A1 CA 2216260A1
Authority
CA
Canada
Prior art keywords
ghrh
growth hormone
ghrp
trp
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2216260
Other languages
English (en)
Inventor
Barry B. Bercu
Richard F. Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Florida
Original Assignee
Barry B. Bercu
University Of South Florida
Richard F. Walker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/722,294 external-priority patent/US5811074A/en
Application filed by Barry B. Bercu, University Of South Florida, Richard F. Walker filed Critical Barry B. Bercu
Publication of CA2216260A1 publication Critical patent/CA2216260A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2216260 1996-09-30 1997-09-23 Methode pour diagnostiquer la carence en hormone de croissance hypophysaire Abandoned CA2216260A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/722,294 US5811074A (en) 1992-06-29 1996-09-30 Method of diagnosing pituitary dependent growth hormone deficiency
US08/722,294 1996-09-30

Publications (1)

Publication Number Publication Date
CA2216260A1 true CA2216260A1 (fr) 1998-03-30

Family

ID=24901243

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2216260 Abandoned CA2216260A1 (fr) 1996-09-30 1997-09-23 Methode pour diagnostiquer la carence en hormone de croissance hypophysaire

Country Status (1)

Country Link
CA (1) CA2216260A1 (fr)

Similar Documents

Publication Publication Date Title
Corpas et al. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men
Nakagawa et al. Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose
Ghigo et al. Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults
Jaffe et al. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
Luciano et al. Hyperprolactinemia in polycystic ovary syndrome
Chapman et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects
Vittone et al. Effects of single nightly injections of growth hormone—releasing hormone (GHRH 1–29) in healthy elderly men
Allain et al. Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome
Ghigo et al. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature
Friend et al. The orderliness of the growth hormone (GH) release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days
Veldhuis et al. Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals
Ranke Diagnosis of growth hormone deficiency and growth hormone stimulation tests
Micic et al. Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease
Baranowska Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa?
US5811074A (en) Method of diagnosing pituitary dependent growth hormone deficiency
Robertson et al. Prolactin response to morphine in depression
LOCHE et al. Augmentation of growth hormone secretion in children with constitutional growth delay by short term clonidine administration: a pulse amplitude-modulated phenomenon
Facchinetti et al. Neuroendocrine evaluation of central opiate activity in primary headache disorders
Ranke et al. Testing with growth hormone-releasing factor (GRF (1–29) NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency
SHULMAN et al. Evaluation of Growth Hormone Secretion: Provocative Testing vs Endogenous 24‐hour Growth Hormone Profile
Ho et al. Defining growth hormone deficiency in adults
EP0871392A1 (fr) Methode de diagnostic de carences en hormone de croissance hypophysaire
CA2216260A1 (fr) Methode pour diagnostiquer la carence en hormone de croissance hypophysaire
WO1994000759A1 (fr) Procedure de diagnostic permettant d'evaluer l'etiologie de l'insuffisance staturale
Aimaretti et al. Short procedure of GHRH plus arginine test in clinical practice

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead